These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7673235)

  • 21. Rat dihydroorotate dehydrogenase: isolation of the recombinant enzyme from mitochondria of insect cells.
    Knecht W; Altekruse D; Rotgeri A; Gonski S; Löffler M
    Protein Expr Purif; 1997 Jun; 10(1):89-99. PubMed ID: 9179295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification, and characterization of histidine-tagged rat and human flavoenzyme dihydroorotate dehydrogenase.
    Bader B; Knecht W; Fries M; Löffler M
    Protein Expr Purif; 1998 Aug; 13(3):414-22. PubMed ID: 9693067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Catalytic enzyme histochemistry and biochemical analysis of dihydroorotate dehydrogenase/oxidase and succinate dehydrogenase in mammalian tissues, cells and mitochondria.
    Löffler M; Becker C; Wegerle E; Schuster G
    Histochem Cell Biol; 1996 Feb; 105(2):119-28. PubMed ID: 8852433
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.
    Cao WW; Kao PN; Chao AC; Gardner P; Ng J; Morris RE
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1016-30. PubMed ID: 8719445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The active metabolite of leflunomide, A77 1726, increases the production of IL-1 receptor antagonist in human synovial fibroblasts and articular chondrocytes.
    Palmer G; Burger D; Mezin F; Magne D; Gabay C; Dayer JM; Guerne PA
    Arthritis Res Ther; 2004; 6(3):R181-9. PubMed ID: 15142263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drosophila melanogaster dihydroorotate dehydrogenase: the N-terminus is important for biological function in vivo but not for catalytic properties in vitro.
    Löffler M; Knecht W; Rawls J; Ullrich A; Dietz C
    Insect Biochem Mol Biol; 2002 Sep; 32(9):1159-69. PubMed ID: 12213251
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leflunomide and malononitrilamides.
    Silva Júnior HT; Morris RE
    Am J Med Sci; 1997 May; 313(5):289-301. PubMed ID: 9145039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plant dihydroorotate dehydrogenase differs significantly in substrate specificity and inhibition from the animal enzymes.
    Ullrich A; Knecht W; Piskur J; Löffler M
    FEBS Lett; 2002 Oct; 529(2-3):346-50. PubMed ID: 12372626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis of beta-hydroxy-propenamide derivatives and the inhibition of human dihydroorotate dehydrogenase.
    Kim TH; Na HS; Löffler M
    Arch Pharm Res; 2003 Mar; 26(3):197-201. PubMed ID: 12723931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-peptide immunoglobulins from rabbit and chicken eggs recognise recombinant human dihydroorotate dehydrogenase and a 44-kDa protein from rat liver mitochondria.
    Knecht W; Köhler R; Minét M; Löffler M
    Eur J Biochem; 1996 Mar; 236(2):609-13. PubMed ID: 8612635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two activities of the immunosuppressive metabolite of leflunomide, A77 1726. Inhibition of pyrimidine nucleotide synthesis and protein tyrosine phosphorylation.
    Xu X; Williams JW; Gong H; Finnegan A; Chong AS
    Biochem Pharmacol; 1996 Aug; 52(4):527-34. PubMed ID: 8759024
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leflunomide inhibits PDK1/Akt pathway and induces apoptosis of human mast cells.
    Sawamukai N; Saito K; Yamaoka K; Nakayamada S; Ra C; Tanaka Y
    J Immunol; 2007 Nov; 179(10):6479-84. PubMed ID: 17982036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dihydroorotate dehydrogenase is a target for the biological effects of leflunomide.
    Williamson RA; Yea CM; Robson PA; Curnock AP; Gadher S; Hambleton AB; Woodward K; Bruneau JM; Hambleton P; Spinella-Jaegle S; Morand P; Courtin O; Sautés C; Westwood R; Hercend T; Kuo EA; Ruuth E
    Transplant Proc; 1996 Dec; 28(6):3088-91. PubMed ID: 8962196
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of dihydroorotate dehydrogenase activity by brequinar sodium.
    Chen SF; Perrella FW; Behrens DL; Papp LM
    Cancer Res; 1992 Jul; 52(13):3521-7. PubMed ID: 1617622
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of action of leflunomide in rheumatoid arthritis.
    Fox RI
    J Rheumatol Suppl; 1998 Jul; 53():20-6. PubMed ID: 9666414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirements for the mitochondrial import and localization of dihydroorotate dehydrogenase.
    Rawls J; Knecht W; Diekert K; Lill R; Löffler M
    Eur J Biochem; 2000 Apr; 267(7):2079-87. PubMed ID: 10727948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis, structure-activity relationships, and pharmacokinetic properties of dihydroorotate dehydrogenase inhibitors: 2-cyano-3-cyclopropyl-3-hydroxy-N-[3'-methyl-4'-(trifluoromethyl)phenyl ] propenamide and related compounds.
    Kuo EA; Hambleton PT; Kay DP; Evans PL; Matharu SS; Little E; McDowall N; Jones CB; Hedgecock CJ; Yea CM; Chan AW; Hairsine PW; Ager IR; Tully WR; Williamson RA; Westwood R
    J Med Chem; 1996 Nov; 39(23):4608-21. PubMed ID: 8917650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E. coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases.
    Nørager S; Jensen KF; Björnberg O; Larsen S
    Structure; 2002 Sep; 10(9):1211-23. PubMed ID: 12220493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine.
    Nair RV; Cao W; Morris RE
    Immunol Lett; 1995 Dec; 48(2):77-80. PubMed ID: 8719103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histidine to alanine mutants of human dihydroorotate dehydrogenase. Identification of a brequinar-resistant mutant enzyme.
    Davis JP; Copeland RA
    Biochem Pharmacol; 1997 Aug; 54(4):459-65. PubMed ID: 9313772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.